$560.73
+9.91 (+1.80%)
At Close: Jun 03, 2026
Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Monday, 13'th Apr 2026
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
IDEXX Laboratories Stock Up 39.4% in a Year: What's Driving It?
09:30am, Monday, 13'th Apr 2026
IDXX stock surges over the past year, fueled by strong diagnostics growth, innovation traction and expanding global demand in pet healthcare markets.
IDEXX Laboratories to Release 2026 First Quarter Financial Results
01:00pm, Wednesday, 08'th Apr 2026
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 first quarter financial results for Tues
Idexx (IDXX) Upgraded to Buy: Here's Why
01:00pm, Monday, 06'th Apr 2026
Idexx (IDXX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term
10:46am, Friday, 03'rd Apr 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma
03:00am, Wednesday, 01'st Apr 2026
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Cancer Dx Panel with canine lymphoma detection helps clinicians investigate sooner and plan next steps with confidence.
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Beacon Investment Advisory Services Inc.
03:34am, Monday, 30'th Mar 2026
Beacon Investment Advisory Services Inc. lifted its position in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 11.9% during the undefined quarter, according to its most recent disclosure with th
IDEXX Laboratories, Inc. $IDXX Holdings Raised by Congress Asset Management Co.
02:42pm, Tuesday, 24'th Mar 2026
Congress Asset Management Co. increased its position in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 9,894.0% during the undefined quarter, according to its most recent disclosure with the Sec
Procyon Advisors LLC Buys Shares of 2,905 IDEXX Laboratories, Inc. $IDXX
05:38am, Monday, 23'rd Mar 2026
Procyon Advisors LLC bought a new stake in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission.
Achmea Investment Management B.V. Grows Stake in IDEXX Laboratories, Inc. $IDXX
04:18am, Thursday, 19'th Mar 2026
Achmea Investment Management B.V. grew its stake in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 319.9% in the undefined quarter, according to its most recent disclosure with the Securities an
Banco Bilbao Vizcaya Argentaria S.A. Raises Holdings in IDEXX Laboratories, Inc. $IDXX
05:22am, Tuesday, 17'th Mar 2026
Banco Bilbao Vizcaya Argentaria S.A. lifted its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 342.3% during the undefined quarter, according to its most recent disclosure with the Securities
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock
10:45am, Tuesday, 10'th Mar 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
IDEXX Laboratories Stock Climbs 39.4% in a Year: What's Driving It?
02:06pm, Monday, 09'th Mar 2026
IDXX shares jump 39% in a year, as CAG Diagnostics' recurring revenues, diagnostic innovations and software growth fuel momentum.
SONVY vs. IDXX: Which Stock Should Value Investors Buy Now?
12:40pm, Monday, 09'th Mar 2026
Investors with an interest in Medical - Instruments stocks have likely encountered both SONOVA HOLDING (SONVY) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value
IDEXX Laboratories (NASDAQ:IDXX) EVP Sells $1,115,574.06 in Stock
06:18am, Sunday, 08'th Mar 2026
IDEXX Laboratories, Inc. (NASDAQ: IDXX - Get Free Report) EVP Nimrata Hunt sold 1,758 shares of the business's stock in a transaction on Tuesday, March 3rd. The shares were sold at an average price of
Sign In
Buy IDXX